Table 1.
The clinic and biochemical data in women with polycystic ovary syndrome (PCOS) and healthy controls
| |
PKOS |
Control |
P |
|---|---|---|---|
| (n =47) | (n=30) | ||
| Age, year |
23.27±5.83 |
22.80±4.4 |
0.704 |
| BMI, kg/m2 |
24.41±4.39 |
23.64± 3.35 |
0.412 |
| Fasting glukose, mg/dL |
94.63±11.01 |
87.66±9.59 |
0.006 |
| Fasting insülin, μ IU/mL |
15.44± 7.98 |
11.34±5.52 |
0.017 |
| HOMA-IR |
2.22± 1.89 |
1.46±0.69 |
0.034 |
| Total cholesterol, mg/dL |
170.46±26.9 |
156.06±27.3 |
0.101 |
| Triglyceride, mg/dL |
109.29±59.46 |
89.13±52.82 |
0.05 |
| HDL-C, mg/dL |
54.21±12.12 |
53.31±14.52 |
0.771 |
| LDL-C, mg/dL |
95.09±23.54 |
84.58±24.18 |
0.128 |
| hsCRP, mg/L | 2.83±4.6 | 1.35±1.81 | 0.03 |
HOMA-IR: homeostasis model assessment insulin resistance index; HDL-C: high density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; hs-CRP: high-sensitive C- reactive protein.